Twin Peaks Wealth Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-78
Closed -$8.52K 1338
2026
Q1
$8.52K Buy
+78
New +$7.43K ﹤0.01% 1143
2025
Q3
Sell
-35
Closed -$3.3K 1264
2025
Q2
$3.3K Buy
+35
New +$2.92K ﹤0.01% 1472

Other funds holding LMAT

Twin Peaks Wealth Advisors's LMAT Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 78 shares — an estimated $8.52K sold.

Twin Peaks Wealth Advisors first reported a position in LMAT in Q2 2025 and held it in 2 quarters. The position peaked at $8.52K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 78 LeMaitre Vascular shares in Q2 2026, an estimated $8.52K.
  • Twin Peaks Wealth Advisors first reported a position in LeMaitre Vascular in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's LeMaitre Vascular position peaked at $8.52K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.